Int J Oncol 2007,31(4):741–751.PubMed HDAC activity assay 47. Shi WD, Meng ZQ, Chen Z, Lin JH, Zhou ZH, Liu LM: Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysis. Cancer Lett 2009,283(1):84–91.PubMedCrossRef 48. Fu Y, Zheng S, An N, Athanasopoulos T, Popplewell L, Liang A, Li K, Hu C,

Zhu Y: Beta-catenin as a potential key target for tumor suppression. Int J Cancer 2011,129(7):1541–1551.PubMedCrossRef 49. Orlichenko LS, Radisky DC: Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin Exp Metastasis 2008,25(6):593–600.PubMedCrossRef 50. Huang C, Xie K: Crosstalk of Sp1 and Stat3 signalling in pancreatic cancer pathogenesis. Cytokine Growth Factor Rev 2012,23(1–2):25–35.PubMedCrossRef 51. Decarlo K, Emley A, Dadzie OE, Mahalingam M: Laser capture microdissection: methods and applications. Methods Mol Biol 2011, 755:1–15.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions AVDB designed

and performed the study, analysed see more the data and wrote the Pitavastatin purchase manuscript. HV participated in drafting the manuscript. RVE has been involved in analysing the data. OG contributed to data collection and data analysis and revised the manuscript. BT conceived and designed the study, interpreted the data and wrote the manuscript. All authors read and approved the final manuscript.”
“Background Gliomas are neuroectodermal tumors contributing to 30–45% of all human intracranial tumors that commonly arise in the white matter of cerebral hemisphere [1]. Due to its highly invasive ability, angiogenesis and the presence of necrosis surrounding brain [2, 3], malignant gliomas are often incurable by surgery alone. The molecular pathogenesis of malignant gliomas is still unclear, thus a major research effort has been directed at identifying novel specific glioma-associated genes which might play significant roles in glioma carcinogenesis. The LATS1 gene, a

mammalian homolog of fly LATS originally isolated in Drosophila as a cell proliferation inhibitor [4, 5], is a speculative serine/threonine kinase that localizes to the mitotic Interleukin-2 receptor apparatus. In mammalian cells, LATS1 is phosphorylated in a cell-cycle-dependent manner and complexes with CDC2 in early mitosis. The N-terminal region of the LATS1 protein binds CDC2 to form a complex showing decreased H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A [6]. Lats1- knockout mice spontaneously developed large soft tissue sarcomas and ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments, suggesting that Lats1 is a tumor suppressor at least in mice [7]. The human LATS1 gene has been mapped to chromosome 6q24-25 where loss of heterozygosity has been observed in ovarian [8], cervical [9], and breast cancers [10].